QIAGEN N.V.reports its annual results under U.S. GAAP (SEC filing) due to the listing of our stock at the New York Stock Exchange. As a company established under the laws of The Netherlands we are required by law to also report under IFRS accounting standards.
Visit our 2021 Financial Report Overview here